Renaissance Technologies - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 262 filers reported holding MYRIAD GENETICS INC in Q2 2013. The put-call ratio across all filers is 3.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2022$217
-100.0%
14,974
-91.2%
0.00%
-100.0%
Q3 2022$3,239,000
+91.3%
169,774
+82.2%
0.01%
+150.0%
Q2 2022$1,693,000
-29.6%
93,200
-2.4%
0.00%
-33.3%
Q1 2022$2,406,000
+129.6%
95,474
+151.4%
0.00%
+200.0%
Q4 2021$1,048,000
-84.7%
37,974
-82.1%
0.00%
-88.9%
Q3 2021$6,832,000
+211.7%
211,574
+195.2%
0.01%
+200.0%
Q2 2021$2,192,000
+123.9%
71,674
+44.8%
0.00%
+200.0%
Q4 2020$979,000
-30.5%
49,491
-54.2%
0.00%0.0%
Q3 2020$1,408,000
+138.6%
107,974
+107.6%
0.00%0.0%
Q2 2020$590,000
-77.4%
52,000
-45.8%
0.00%
-50.0%
Q4 2019$2,611,000
-66.2%
95,900
-62.0%
0.00%
-50.0%
Q2 2018$7,736,000
+21.6%
252,074
+17.1%
0.00%
-42.9%
Q1 2018$6,361,000
-14.8%
215,274
-0.9%
0.01%
-12.5%
Q4 2017$7,462,000
+28.8%
217,279
+35.7%
0.01%
+14.3%
Q3 2017$5,795,000
-43.6%
160,174
-70.0%
0.01%
-50.0%
Q1 2017$10,266,000
-77.1%
534,700
-80.1%
0.01%
-80.3%
Q4 2016$44,779,000
-25.8%
2,686,174
-8.4%
0.07%
-33.6%
Q3 2016$60,334,000
+48.0%
2,931,674
+120.0%
0.11%
+37.2%
Q2 2016$40,768,000
+5.3%
1,332,300
+28.7%
0.08%
+5.4%
Q1 2016$38,733,000
-5.5%
1,034,800
+9.0%
0.07%
-16.9%
Q4 2015$40,985,000
+27.7%
949,600
+10.9%
0.09%
+15.6%
Q3 2015$32,105,000
+47.6%
856,600
+33.9%
0.08%
+54.0%
Q2 2015$21,747,000
+124.5%
639,800
+133.8%
0.05%
+138.1%
Q1 2015$9,689,000
+202.6%
273,700
+191.2%
0.02%
+162.5%
Q4 2014$3,202,000
+37.3%
94,000
+55.4%
0.01%
+33.3%
Q3 2014$2,332,000
+21.8%
60,474
+22.9%
0.01%
+50.0%
Q2 2014$1,915,000
-10.8%
49,200
-21.7%
0.00%
-20.0%
Q1 2014$2,147,000
-71.8%
62,800
-82.7%
0.01%
-72.2%
Q4 2013$7,609,000
-87.2%
362,700
-85.7%
0.02%
-87.5%
Q3 2013$59,550,000
-2.8%
2,534,031
+11.2%
0.14%
-10.6%
Q2 2013$61,247,0002,279,3740.16%
Other shareholders
MYRIAD GENETICS INC shareholders Q2 2013
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders